Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial.
Tavenier AH, Hermanides RS, Ottervanger JP, Tolsma R, van Beurden A, Slingerland RJ, Ter Horst PGJ, Gosselink ATM, Dambrink JE, van Leeuwen MAH, Roolvink V, Kedhi E, Klungel OH, Belitser SV, Angiolillo DJ, Pustjens T, Rasoul S, Gho B, Stein M, Ruiters L, van 't Hof AWJ. Tavenier AH, et al. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 5;8(1):4-12. doi: 10.1093/ehjcvp/pvaa095. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 32730628 Free PMC article. Clinical Trial.
Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y12 inhibitors in ST-segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial.
Tavenier AH, Claassens DMF, Hermanides RS, Vos GJA, Bergmeijer TO, Kelder JC, Deneer VHM, van 't Hof AWJ, Ten Berg JM. Tavenier AH, et al. Catheter Cardiovasc Interv. 2022 Feb;99(3):676-685. doi: 10.1002/ccd.29861. Epub 2021 Jul 7. Catheter Cardiovasc Interv. 2022. PMID: 34233065 Clinical Trial.
Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial.
Tavenier AH, Hermanides RS, Fabris E, Lapostolle F, Silvain J, Ten Berg JM, Lassen JF, Bolognese L, Cantor WJ, Cequier Á, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Ecollan P, Collet JP, Willems FF, Diallo A, Vicaut E, Hamm CW, Montalescot G, van 't Hof AWJ; ATLANTIC investigators. Tavenier AH, et al. Thromb Haemost. 2020 Jan;120(1):65-74. doi: 10.1055/s-0039-1700546. Epub 2019 Nov 21. Thromb Haemost. 2020. PMID: 31752042 Free article. Clinical Trial.
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis.
Tavenier AH, Mehran R, Chiarito M, Cao D, Pivato CA, Nicolas J, Beerkens F, Nardin M, Sartori S, Baber U, Angiolillo DJ, Capodanno D, Valgimigli M, Hermanides RS, van 't Hof AWJ, Ten Berg JM, Chang K, Kini AS, Sharma SK, Dangas G. Tavenier AH, et al. Eur Heart J Cardiovasc Pharmacother. 2022 Aug 11;8(5):492-502. doi: 10.1093/ehjcvp/pvab068. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34459481
Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age Trial.
Gimbel ME, Tavenier AH, Bor W, Hermanides RS, de Vrey E, Heestermans T, Gin MTJ, Waalewijn R, Hofma S, den Hartog F, Jukema W, von Birgelen C, Voskuil M, Kelder J, Deneer V, Ten Berg JM. Gimbel ME, et al. Among authors: tavenier ah. J Clin Med. 2020 Oct 12;9(10):3249. doi: 10.3390/jcm9103249. J Clin Med. 2020. PMID: 33053622 Free PMC article.
21 results